Design Therapeutics, Inc. (DSGN) stock
DSGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.47−0.37 (-3.76%)
Close on Nov 18, 2026Market cap $592.65MP/E –Yield –
Design Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Design Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $0. For fiscal 2025 it was $0.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | – |
| FY2024 | Dec 31, 2024 | $0 | -100.0% |
| FY2020 | Dec 31, 2020 | $226.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0 | – |
| Q1 FY2026 | Mar 31, 2026 | $0 | – |
| Q4 FY2025 | Dec 31, 2025 | $0 | -100.0% |
| Q3 FY2025 | Sep 30, 2025 | $0 | -100.0% |
| Q2 FY2025 | Jun 30, 2025 | $0 | -100.0% |
| Q1 FY2025 | Mar 31, 2025 | $0 | -100.0% |
| Q4 FY2020 | Dec 31, 2020 | $33.00K | – |
| Q3 FY2020 | Sep 30, 2020 | $20.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $31.00K | – |
| Q1 FY2020 | Mar 31, 2020 | $142.00K | – |
See a number that looks wrong?